Extending our reach
In view of our vision of a world free of pain, Grünenthal strives to provide effective medication to patients worldwide. We continuously grow and expand our market presence and product portfolio, and we collaborate with commercial partners and multiple stakeholders from the pain management field and beyond in order to make our medicines available to patients.
Grünenthal’s field teams currently comprise approximately 1,400 people distributed across Europe, Latin America and the US. Their overall focus is on pain and mature brands, while our teams in Latin America focus on other therapeutic areas as well, e.g. women’s health. In 2019, our field teams visited nearly 300,000 stakeholders, including physicians, pharmacists, nurses, and administrative staff within the healthcare system.
In addition, Grünenthal has built a strong network of commercial partners in countries where we do not maintain our own local commercial organisation.